If you are wondering whether Incyte's share price still offers value after its recent run, you are not alone. The stock closed at US$103.43 recently, with a 3% decline over the last 7 days, an 8.4% ...
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Incyte (INCY), which belongs to the Zacks Medical ...
Incyte recently reported positive topline results from its pivotal Phase 3 frontMIND trial, where adding tafasitamab (Monjuvi/Minjuvi) and lenalidomide to R-CHOP improved progression-free survival for ...
Chambliss explains the task of designing a movie-within-a-movie that feels "inevitable" once the actors arrive on set. What to do when faced with the task of figuring the production design for not ...
Sulfur caves are among the most extreme habitats on Earth. They are completely dark and filled with hydrogen sulfide gas, which is toxic to most life-forms. Inside, species’ survival depends on ...
Greetings, and welcome to the Incyte Third Quarter 2025 Earnings Conference Call webcast [Operator Instructions]. As a reminder, this conference is being recorded. It's now my pleasure to turn the ...
Fintel reports that on October 9, 2025, JP Morgan maintained coverage of Incyte (NasdaqGS:INCY) with a Neutral recommendation. Analyst Price Forecast Suggests 1.36% Upside As of September 29, 2025, ...
Incyte Corporation (NASDAQ:INCY) ranks among the best biotech stocks to buy. RBC Capital retained its Sector Perform rating on Incyte Corporation (NASDAQ:INCY) and increased its price target from $72 ...
Spider-Man fans will have to wait just a little bit longer to go “Beyond the Spider-Verse.” The third film in Sony’s popular web-slinging animated series has shifted its release date back by three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results